Oct 17 (Reuters) - U.S. Patent and Trademark Office director John Squires announced on Friday that he will determine whether the office's Patent Trial and Appeal Board will hear challenges to the ...

Flaherty & Crumrine Preferred Income Opportunity Fund remains a buy, offering a 6.3% yield and trading at a 6.54% discount to NAV. PFO provides diversified exposure to preferred securities, with a ...

St. Luke's Health-Memorial Hospital Lufkin recently announced a significant advancement in cardiovascular care, becoming the first and only hospital in Deep East Texas to successfully perform a ...

This article is part of Kotaku Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. We’re still a solid week away from Prime Big Deals ...

Background: Patent foramen ovale (PFO) is strongly associated with cryptogenic stroke (CS), but the underlying mechanisms remain incompletely understood. The glymphatic system plays a crucial role in ...

While other device-based closures have demonstrated notable rates of atrial fibrillation (5.7–6.6%) and device-related adverse events, the NobleStitch™ system's fully suture-mediated approach ...

Alkermes filed a patent infringement lawsuit against Teva Pharmaceuticals, Apotex and MSN Pharmaceuticals for trying to make generic versions of its schizophrenia and bipolar treatment Lybalvi. The ...

Sept 12 (Reuters) - Samsung (005930.KS), opens new tab has agreed to settle a patent lawsuit over wireless communications technology that led to a $279 million jury verdict against the Korean tech ...

GM has filed a patent application for a pet carrier system designed to integrate directly with a vehicle seat. The patent application was tagged with publication number US 2025/0263018 A1 with the ...

The Trump administration is considering a plan to raise tens of billions of dollars with a new fee that would transform the patent system, a radical move that would likely fuel pushback from ...

I rate PFO a buy due to its attractive discount to NAV and a compelling 6.6% dividend yield for income-focused investors. PFO's performance is highly sensitive to interest rates; future rate cuts ...